Korea hypertension fact sheet 2022: analysis of nationwide population-based data with a special focus on hypertension in the elderly.

Awareness Elderly Hypertension Korea Prevalence Therapeutics

Journal

Clinical hypertension
ISSN: 2056-5909
Titre abrégé: Clin Hypertens
Pays: England
ID NLM: 101669508

Informations de publication

Date de publication:
15 Aug 2023
Historique:
received: 15 01 2023
accepted: 25 05 2023
medline: 15 8 2023
pubmed: 15 8 2023
entrez: 14 8 2023
Statut: epublish

Résumé

The Korean Society of Hypertension has published the Korea Hypertension Fact Sheet 2022 to provide an overview of the magnitude and management status of hypertension and their recent trends. The Fact Sheets were based on the analyses of Korean adults aged 20 years or older of the 1998-2020 Korea National Health and Nutrition Examination Survey and the 2002-2020 National Health Insurance Big Data. As of 2020, 29.4% of the adult population aged 20 or older in Korea, about 12.6 million people, have high blood pressure, of which 5.0 million (40%) are 65 years of age or older and 1.2 million (10%) are 80 years of age or older. Among those with hypertension, the awareness rate is 69%, the treatment rate is 65%, and the control rate is 47%. The number of people diagnosed with hypertension increased from 3.0 million in 2002 to 10.5 million in 2020. During the same period, the number of people using antihypertensive medication increased from 2.5 million to 9.9 million, and the number of people adherent to treatment increased from 0.6 million to 7.4 million. Among those treated for hypertension in 2020, 74% used angiotensin blockers, 61% used calcium channel blockers, 24% used diuretics, and 15% used beta blockers. Combination therapy with at least two classes of antihypertensive medication consisted of 60% of all antihypertensive prescriptions. The number of people with hypertension aged 65 or older is increasing very rapidly compared to those aged 20-64. Awareness and treatment rates of hypertension improved rapidly, especially in those aged 65 or older, but the rate of improvement slowed since 2012. In Korea, the level of hypertension management is improving, but the absolute number of people with hypertension, especially elderly hypertension, is increasing due to the rapid aging of the population. It is necessary to develop more efficient and target-specific policies to control blood pressure and prevent cardiovascular disease.

Sections du résumé

BACKGROUND BACKGROUND
The Korean Society of Hypertension has published the Korea Hypertension Fact Sheet 2022 to provide an overview of the magnitude and management status of hypertension and their recent trends.
METHODS METHODS
The Fact Sheets were based on the analyses of Korean adults aged 20 years or older of the 1998-2020 Korea National Health and Nutrition Examination Survey and the 2002-2020 National Health Insurance Big Data.
RESULTS RESULTS
As of 2020, 29.4% of the adult population aged 20 or older in Korea, about 12.6 million people, have high blood pressure, of which 5.0 million (40%) are 65 years of age or older and 1.2 million (10%) are 80 years of age or older. Among those with hypertension, the awareness rate is 69%, the treatment rate is 65%, and the control rate is 47%. The number of people diagnosed with hypertension increased from 3.0 million in 2002 to 10.5 million in 2020. During the same period, the number of people using antihypertensive medication increased from 2.5 million to 9.9 million, and the number of people adherent to treatment increased from 0.6 million to 7.4 million. Among those treated for hypertension in 2020, 74% used angiotensin blockers, 61% used calcium channel blockers, 24% used diuretics, and 15% used beta blockers. Combination therapy with at least two classes of antihypertensive medication consisted of 60% of all antihypertensive prescriptions. The number of people with hypertension aged 65 or older is increasing very rapidly compared to those aged 20-64. Awareness and treatment rates of hypertension improved rapidly, especially in those aged 65 or older, but the rate of improvement slowed since 2012.
CONCLUSIONS CONCLUSIONS
In Korea, the level of hypertension management is improving, but the absolute number of people with hypertension, especially elderly hypertension, is increasing due to the rapid aging of the population. It is necessary to develop more efficient and target-specific policies to control blood pressure and prevent cardiovascular disease.

Identifiants

pubmed: 37580841
doi: 10.1186/s40885-023-00243-8
pii: 10.1186/s40885-023-00243-8
pmc: PMC10426053
doi:

Types de publication

Journal Article

Langues

eng

Pagination

22

Subventions

Organisme : Korean Society of Hypertension
ID : KSH-P-2022-1

Informations de copyright

© 2023. The Author(s).

Références

Int J Epidemiol. 2017 Jun 1;46(3):799-800
pubmed: 27794523
Lancet. 2021 Sep 11;398(10304):957-980
pubmed: 34450083
Epidemiol Health. 2021;43:e2021025
pubmed: 33872484
Clin Hypertens. 2019 Aug 1;25:16
pubmed: 31388451
Lancet Neurol. 2016 Aug;15(9):913-924
pubmed: 27291521
Korean Circ J. 2021 Jun;51(6):495-503
pubmed: 34085422
Clin Hypertens. 2022 Jan 3;28(1):1
pubmed: 34980274
Clin Hypertens. 2018 Oct 01;24:13
pubmed: 30288297
Lancet. 2006 May 27;367(9524):1747-57
pubmed: 16731270
Epidemiol Health. 2022;44:e2022041
pubmed: 35538699
Clin Hypertens. 2021 Mar 15;27(1):8
pubmed: 33715619
Korean Circ J. 2021 Apr;51(4):320-332
pubmed: 33821581

Auteurs

Hyeon Chang Kim (HC)

Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea. hckim@yuhs.ac.
Institute for Innovation in Digital Healthcare, Yonsei University Health System, Seoul, Republic of Korea. hckim@yuhs.ac.

Hokyou Lee (H)

Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
Institute for Innovation in Digital Healthcare, Yonsei University Health System, Seoul, Republic of Korea.

Hyeok-Hee Lee (HH)

Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.

Gabin Lee (G)

Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.

Eunji Kim (E)

Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.

Moses Song (M)

Institute for Innovation in Digital Healthcare, Yonsei University Health System, Seoul, Republic of Korea.

Jenny Moon (J)

Department of Public Health, Yonsei University Graduate School, Seoul, Republic of Korea.

Yeeun Seo (Y)

Department of Public Health, Yonsei University Graduate School, Seoul, Republic of Korea.

Classifications MeSH